BIAFW 0.85 bioAffinity Technologies, Inc.
| Range: | 0.7821-1.09 | Vol Avg: | 0 | Last Div: | 0 | Changes: | -0.23 |
| Beta: | 2.93 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jan 01 1970 | Empoloyees: | 14 | ||
| CUSIP: | 09076W117 | CIK: | 0001712762 | ISIN: | US09076W1172 | Country: | US |
| CEO: | Ms. Maria Zannes J.D. | Website: | https://www.bioaffinitytech.com | ||||
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow